PEOPLE - ExonHit Therapeutics (Brunel, Paris) makes appointment:
This article was originally published in Clinica
Diagnostics and drug discovery firm ExonHit Therapeutics (Brunel, Paris) has appointed Deborah Smeltzer as a member of its supervisory board. Ms Smeltzer is vice-president of operations and CFO at biopharma firm Dynavax Technologies (California). Her more than 20 years' operating and financial expertise covers the markets of biotechnology (in Europe and the US), genomic analysis, diagnostics and vaccines.